Results 11 to 20 of about 2,545,005 (248)
Current strategies of antiarrhythmic drug therapy for paroxysmal atrial fibrillation [PDF]
Atrial fibrillation is now recognized as a significant medical and social problem. Atrial fibrillation not only causes cardiovascular complications, including thromboembolism and heart failure, but also decreases the survival of patients with impaired ...
Takashi Komatsu
doaj +2 more sources
Safety issues of antiarrhythmic therapy for atrial fibrillation
The article discusses the safety of antiarrhythmic therapy for atrial fibrillation in the light of the development of cardiac and non-cardiac side effects, the presence of drug-drug interactions of antiarrhythmic drugs in the near (with anticoagulants ...
I.I. Reznik , Ya.G. Bozhko
doaj +2 more sources
Future evaluation of antiarrhythmic therapy
The expension of antiarrhythmic therapy beyond pharmacologic agents to include surgary, devices, and ablation procedures, plus the reaffirmation by the Cardiac Arrhythmia Suppression Trial (CAST) of the need for concurrent placebo-controlled trials to ...
Kessler, Kenneth M +6 more
core +3 more sources
The work has studied opportunities for ТЕ EPS in serial testing of antiarrhythmic drugs testing to prevent recurrent arrhythmia in patients with atrial fibrillation.
K. A. Skiba, V. V. Petry, V. A. Sulimov
doaj +1 more source
SIDE EFFECTS OF PROLONGED ANTIARRHYTHMIC THERAPY WITH AMIODARONE
Atrial fibrillation is widespread in population. It determines extensive use of antiarrhythmic drugs such as amiodarone. Thyroid lesion is one of common side effects of this therapy. The article describes a clinical case of photosensitivity’s development
N P Dorofeeva +7 more
doaj +2 more sources
Antiarrhythmic therapy in pregnancy
Arrhythmia is a common cardiovascular disease (CVD) that can lead to hemodynamic instability, worsening the pregnant woman’s condition (gestosis, threatened miscarriage, placental abruption, pregnancy loss, fetal hypoxia), the fetus’s condition ...
Khafiza G. Alidzhanova +4 more
doaj +2 more sources
Revisiting Antiarrhythmic Drug Therapy for Atrial Fibrillation: Reviewing Lessons Learned and Redefining Therapeutic Paradigms [PDF]
Since the clinical use of digitalis as the first pharmacological therapy for atrial fibrillation (AF) 235 years ago in 1785, antiarrhythmic drug therapy has advanced considerably and become a cornerstone of AF clinical management.
Meng Geng, Andrew Lin, Thao P. Nguyen
doaj +2 more sources
The efficiency of multimodality therapy with use standard antiarrhythmic drugs (cordaron and propanorm) in minimum efficient doses and phencarol (1-2 mg/kg) was investigated in 50 children's with extrasistoles, class II-IV by Lown, as compared with ...
O N Soldatova +6 more
doaj +1 more source
Arrhythmogenic Right Ventricular Cardiomyopathy - Antiarrhythmic Therapy. [PDF]
Arrhythmogenic right ventricular cardiomyopathy is an inherited disorder characterised by progressive replacement of ventricular myocardium by fibrofatty tissue that predisposes patients to ventricular arrhythmias, heart failure and sudden death ...
Ermakov S, Scheinman M.
europepmc +2 more sources
Potassium channels as targets for antiarrhythmic therapy. [PDF]
Chiamvimonvat N, Zheng Y, Zhang M.
europepmc +4 more sources

